All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

NAD+ IV therapy claims on TikTok: what the science supports

Sam

TikTok creator

101.2K viewsWatch on TikTok→

Quick answer

NAD+ is an endogenous coenzyme involved in mitochondrial energy production and DNA repair, with declining levels associated with aging. Human clinical trial data on injectable NAD+ for fatigue, metabolism, or dermal outcomes remains limited, with most supportive evidence coming from precursor supplementation studies or animal models. The subjective benefits described in this video, including fatigue resolution, weight loss, and skin improvement, are consistent with known placebo response patterns in open-label self-experimentation and cannot be attributed to NAD+ specifically without controlled data.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @y0urfavsam actually say?

The short version: she's been self-injecting 100mg of NAD+ weekly for a few months and credits it with eliminating chronic fatigue, letting her "work out forever," dropping six pounds in two weeks, improving her skin, and stabilizing her mood. She even hedges at the end, wondering aloud if it's placebo. That moment of self-doubt is actually the most scientifically honest thing in the video.

She's describing a broad cluster of benefits across energy metabolism, body composition, skin quality, and mental health, all from a single intervention. That's a lot of weight for one molecule to carry, and it's worth slowing down and asking which of those claims have any research behind them, and which are running ahead of the evidence.

Does the science back this up?

Partially, and with significant caveats. NAD+ is a legitimate area of active research, but the human trial data is still thin, especially for the specific outcomes she describes. Most of what we know comes from animal models or small Phase 1 safety studies in humans.

On fatigue: a 2023 randomized controlled trial by Braidy et al. in Nutrients found that NAD+ precursor supplementation improved self-reported fatigue scores in adults over 40, but these were oral precursors, not IV or subcutaneous NAD+. The delivery method matters enormously for bioavailability. On metabolism: a 2021 study by Yoshino et al. in Science showed NAD+ precursor supplementation improved muscle insulin sensitivity in postmenopausal women, but no significant weight loss was observed. The "six pounds in two weeks" claim has no direct study support. On skin: GHK-Cu peptides have dermal research behind them, but NAD+ and skin quality is mostly theoretical at this point, linked to sirtuin activation and DNA repair, not clinical skin appearance trials.

What did they get wrong (or right)?

She got the general direction right: NAD+ does appear to influence cellular energy pathways. The basic biology is real. NAD+ is a coenzyme in mitochondrial respiration, and declining NAD+ levels are associated with aging and fatigue-related conditions (Verdin, 2015, Science). That part is not controversial.

What she got wrong is the certainty. Saying chronic fatigue is "completely gone" and attributing it entirely to NAD+ injections, without ruling out confounders like improved sleep, placebo effect, or behavioral changes from starting a health routine, is a logical leap the data doesn't support. The six-pound weight loss claim is the weakest. Two weeks is well within normal fluctuation from water weight, glycogen stores, or dietary changes that often accompany starting a new health protocol. Attributing it to NAD+ metabolism regulation is speculative. Her skin claim is also unverifiable and more likely tied to sleep quality or hydration improvements than direct dermal NAD+ effects.

  • Energy improvement: plausible, some supporting data
  • Fatigue elimination: overstated, confounders not ruled out
  • Six-pound weight loss from NAD+: not supported by current evidence
  • Skin improvement: anecdotal, no clinical trial support
  • Mood improvement: has some mechanistic support via SIRT1 pathways, but human data is limited

What should you actually know?

NAD+ therapy is being studied seriously, but it is not FDA-approved for any of the conditions she describes. If you're considering it, the method of administration matters. IV NAD+ has different pharmacokinetics than subcutaneous injection or oral supplementation, and the research doesn't always transfer between routes.

Self-injection without medical supervision carries real risks: infection at injection sites, dosing errors, and interactions with underlying conditions that haven't been evaluated. The fact that she describes this casually as something she does to herself at home, without mentioning any prescribing clinician or monitoring, is worth flagging.

The placebo effect in open-label self-experimentation like this is also not trivial. A 2020 meta-analysis by Hrobjartsson et al. in Cochrane Database of Systematic Reviews found placebo responses are particularly strong for subjective outcomes like fatigue, mood, and pain. Every single benefit she describes is subjective. That doesn't mean her experience isn't real to her. It means we can't attribute it to NAD+ specifically without a controlled comparison.

If you're interested in NAD+ therapy, talk to a licensed clinician who can order baseline labs, assess whether you're actually NAD+-deficient, and monitor your response. This is not a supplement you should be sourcing and self-administering based on TikTok testimonials.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksNAD+ Peptide ComplexProvider discussion

Evidence signal

Source-backed review

Regulatory reality

NAD+ Peptide Complex access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For NAD+ IV therapy claims on TikTok: what the science supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

NAD+ Peptide Complex is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this nad+ video claims cluster

Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.

Claim verdict

The useful answer behind this video

Claim being checked

NAD+ is an endogenous coenzyme involved in mitochondrial energy production and DNA repair, with declining levels associated with aging.

FormBlends verdict

NAD+ is an endogenous coenzyme involved in mitochondrial energy production and DNA repair, with declining levels associated with aging. Human clinical trial data on injectable NAD+ for fatigue, metabolism, or dermal outcomes remains limited, with most supportive evidence coming from precursor supplementation studies or animal models. The subjective benefits described in this video, including fatigue resolution, weight loss, and skin improvement, are consistent with known placebo response patterns in open-label self-experimentation and cannot be attributed to NAD+ specifically without controlled data.

Patient-safe next step

Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • NAD+ is an endogenous coenzyme involved in mitochondrial energy production and DNA repair, with declining levels associated with aging. Human clinical trial data on injectable NAD+ for fatigue, metabolism, or dermal outcomes remains limited, with most supportive evidence coming from precursor supplementation studies or animal models. The subjective benefits described in this video, including fatigue resolution, weight loss, and skin improvement, are consistent with known placebo response patterns in open-label self-experimentation and cannot be attributed to NAD+ specifically without controlled data.
  • No FDA-approved indication exists for injectable NAD+ for fatigue, weight loss, skin quality, or mood, meaning any use for these purposes is off-label.
  • Yoshino et al. (2021, Science) found NAD+ precursor supplementation improved insulin sensitivity in postmenopausal women but did not produce significant weight loss, directly contradicting the six-pound claim.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.

Review NAD+ Peptide Complex

What You'll Learn

  • No FDA-approved indication exists for injectable NAD+ for fatigue, weight loss, skin quality, or mood, meaning any use for these purposes is off-label.
  • Yoshino et al. (2021, Science) found NAD+ precursor supplementation improved insulin sensitivity in postmenopausal women but did not produce significant weight loss, directly contradicting the six-pound claim.
  • Placebo responses are measurably strong for subjective outcomes like fatigue and mood in open-label conditions (Hrobjartsson et al., 2020, Cochrane), and every benefit described in this video is subjective.
  • Delivery route matters: IV, subcutaneous, and oral NAD+ precursors have different bioavailability profiles, and research findings from one method do not automatically apply to another.
  • Self-injecting any compound without clinical supervision creates real risks including injection site infection, dosing error, and unmonitored interactions with underlying health conditions.
  • NAD+ levels do decline with age and this has legitimate research interest (Verdin, 2015, Science), but the gap between that basic biology and the specific outcomes claimed in this video is wide and not yet bridged by human trial data.
  • A prescribing clinician should assess baseline NAD+ status and monitor labs before and during any NAD+ therapy protocol, something not mentioned in this video.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Sam · TikTok creator

101.2K views on this video

@Body Tonic Med Spa @Candice Hessel #fyp #NAD #nadplus #nadtherapy #nadivtherapy #healthandwellness #peptidetherapy

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Sam, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.